Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2019. First-quarter 2019 net sales were $554.0 million, an increase of 0.4 percent compared …